Skip to content

Clinical trials

Multiple Sclerosis trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Sclerosis Country / region: France Clear all

355 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20023
20032
20042
20053
20069
200711
20089
200912
20108
20119
201212
201320
201411
201513
201611
201725
201823
201927
202022
202129
202223
202325
202414
202518
202611

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed209
Unknown status42
Recruiting40
Terminated30
Active, not recruiting24
Not yet recruiting9
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Biogen23
Assistance Publique - Hôpitaux de Paris22
Rennes University Hospital20
University Hospital, Bordeaux17
Fondation Ophtalmologique Adolphe de Rothschild14
Lille Catholic University14
Novartis Pharmaceuticals14
Centre Hospitalier Universitaire de Nice13
Centre Hospitalier Universitaire de Nīmes13
Sanofi13

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Sclerosis355
Multiple Sclerosis, Relapsing-Remitting41
Recurrence17
Multiple Sclerosis, Chronic Progressive12
Fatigue11
Optic Neuritis11
Cognitive Dysfunction8
Neuromyelitis Optica8
Demyelinating Diseases7
Lower Urinary Tract Symptoms7

Trials

Showing 1 to 25 of 355. Each trial links to its page on Pharma Observatory.

255 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.